Catalytic monoclonal antibodies with protease activity for...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/00 (2006.01) C12N 9/00 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2299442

Catalytic monoclonal antibodies (abzymes) with selective protease activity in the pathologies characterized by the presence of plaques and fibrillar aggregates with protein component; methods for the preparation thereof and the use thereof as medicaments in the treatment of pathologies such as Alzheimer's disease, amyloidosis, atherosclerosis, prions diseases.

L'invention concerne des anticorps monoclonaux catalytiques (abzymes) présentant une activité protéase sélective dans les pathologies caractérisées par la présence de plaques et d'agrégats fibrillaires comprenant une fraction protéinique. L'invention concerne également la préparation de ces anticorps et l'utilisation de ces derniers en tant que médicaments dans le traitement de pathologies telles que la maladie d'Alzheimer, l'amylose, l'athérosclérose et les maladies à prions.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Catalytic monoclonal antibodies with protease activity for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Catalytic monoclonal antibodies with protease activity for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Catalytic monoclonal antibodies with protease activity for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1382263

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.